Stoller do Brasil starts operating biologic input plant

Valor Internacional

The Brazilian unit of US company Stoller will inaugurate this Tuesday a new factory of biologic farm inputs in São Paulo. With annual capacity of 20 million doses a year, upgradable to 35 million, and costing R$30 million, the plant is one of the world's biggest in terms of capacity for the segment, Stoller says. Brazilian sales already respond for 50% of the company's global revenues last year.